The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients

被引:2
|
作者
Braga-Diniz, Julia Mourao [1 ]
Santa-Rosa, Caroline Christine [1 ]
Martins, Renata de Castro [2 ]
Souza e Silva, Maria Elisa [1 ]
Vieira, Leda Quercia [3 ]
Ribeiro Sobrinho, Antonio Paulino [1 ]
机构
[1] Univ Fed Minas Gerais, Sch Dent, Dept Operat Dent, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil
来源
BRAZILIAN ORAL RESEARCH | 2017年 / 31卷
关键词
Immunosuppression; Hematopoietic stem cell transplantation; Endodontics; DNA-DNA HYBRIDIZATION; MARROW-TRANSPLANTATION; GLOBAL PERSPECTIVE; INFECTIONS; MICROBIOTA; LEUKEMIA; RECIPIENTS; BACTERIA; DISEASE; BLOOD;
D O I
10.1590/1807-3107BOR-2017.vol31.0050
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this study is to investigate the relationship between the epidemiological and clinical profiles of patients before and after hematopoietic stem cell transplantation (HSCT) and the need for endodontic treatment. The subjects included 188 individuals enrolled in the dental care program for transplanted patients of the School of Dentistry, Federal University of Minas Gerais (Faculdade de Odontologia da Universidade Federal de Minas Gerais, FO-UFMG) from March 2011 through March 2016. The patients were subjected to an HSCT conditioning dental regimen based on a thorough clinical and radiographic evaluation. Intraoral periapical and bite-wing X-rays were obtained, and after evaluation, specific dental treatment was planned and performed. The following demographic and clinical data were collected from the patients' medical records: age, gender, transplantation stage, primary disease, transplant type, medication used, complete blood count at the time of visit, and need for endodontic treatment. The Kolmogorov-Smirnov and the chi-square tests were used. Leukemia (31.3%) and multiple myeloma (17.9%) were the most prevalent primary diseases. Most patients were subjected to allogeneic-related transplantation (83.6%). Most patients exhibited platelet counts and hemoglobin concentrations below the reference values in the pre-transplantation stage, while the neutrophil and platelet counts and the hemoglobin levels were within the reference ranges in the post-transplantation stage. The proportions of individuals requiring endodontic treatment were similar between the pre-and post-transplantation groups: 24.3% and 24.7%, respectively. The systemic conditions of the patients referred for dental treatment were compromised.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Autologous hematopoietic stem cell transplantation experience in patients with diffuse cutaneous systemic scleroderma
    Bazan-Ruiz, Susy
    Aranda, Lourdes
    Wong, Alfredo
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 (04): : 583 - 585
  • [32] SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus
    Richard K Burt
    Ann E Traynor
    Arthritis Res Ther, 5
  • [33] Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation
    J Kuruvilla
    D L Forrest
    J C Lavoie
    S H Nantel
    J D Shepherd
    K W Song
    H J Sutherland
    C L Toze
    D E Hogge
    T J Nevill
    Bone Marrow Transplantation, 2004, 34 : 969 - 973
  • [34] Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation
    Kuruvilla, J
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Shepherd, JD
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Nevill, TJ
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 969 - 973
  • [35] Hematopoietic stem-cell transplantation for systemic lupus erythematosus
    Burt, RK
    Traynor, A
    RamseyGoldman, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24): : 1777 - 1778
  • [36] Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
    Henrique-Neto, Alvaro
    Vasconcelos, Marianna Yumi Kawashima
    Dias, Juliana Bernardes Elias
    de Moraes, Daniela Aparecida
    Goncalves, Maynara Santana
    Zanin-Silva, Djulio Cesar
    Zucoloto, Talita Graminha
    de Oliveira, Marilia de Fatima Cirioli
    Dotoli, Giuliana Martinelli
    Weffort, Luiz Fernando
    Leopoldo, Vanessa Cristina
    Oliveira, Maria Carolina
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [37] Hematopoietic stem-cell transplantation in systemic sclerosis: an update
    Spierings, Julia
    van Rhijn-Brouwer, Femke C. C.
    van Laar, Jacob M.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (06) : 541 - 547
  • [38] Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus
    Alexander, T.
    Arnold, R.
    Hiepe, F.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (08): : 770 - 779
  • [39] Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus
    Burt, RK
    Traynor, A
    Statkute, L
    Barr, WG
    Rosa, R
    Schroeder, J
    Verda, L
    Krosnjar, N
    Quigley, K
    Yaung, K
    Villa, M
    Takahashi, M
    Jovanovic, B
    Oyama, Y
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05): : 527 - 535
  • [40] Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Systemic Mastocytosis
    Christen, Deborah
    Luebke, Johannes
    Kaiser, Anne
    Schwaab, Juliana
    Shoumariyeh, Khalid
    Jentzsch, Madlen
    Sockel, Katja
    Schaffrath, Judith
    Ayuk, Francis A.
    Stelljes, Matthias
    Hilgendorf, Inken
    Sala, Elisa
    Kaivers, Jennifer
    Schoenland, Stefan
    Wittke, Christoph
    Hertenstein, Bernd
    Radsak, Markus P.
    Kaiser, Ulrich
    Brueckl, Valeska
    Kroeger, Nicolaus
    Klein, Stefan
    Hofmann, Wolf-Karsten
    Bruemmendorf, Tim H.
    Jost, Edgar
    Panse, Jens
    Reiter, Andreas
    BLOOD, 2023, 142